PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
150.15%
Net income growth 1.25-1.5x CNQ's 102.92%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
5.84%
Some D&A expansion while CNQ is negative at -2.84%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
11.63%
Lower deferred tax growth vs. CNQ's 27.14%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
No Data
No Data available this quarter, please select a different quarter.
98.40%
Well above CNQ's 26.12% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
98.40%
Growth well above CNQ's 26.12%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
160.04%
Well above CNQ's 123.81%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
107.95%
Operating cash flow growth above 1.5x CNQ's 29.64%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-10.91%
Both yoy lines negative, with CNQ at -178.34%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-100.00%
Negative yoy acquisition while CNQ stands at 100.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-100.00%
Negative yoy purchasing while CNQ stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-100.00%
We reduce yoy sales while CNQ is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
208.20%
Growth well above CNQ's 229.06%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
94.82%
Investing outflow well above CNQ's 21.96%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
7.38%
Lower share issuance yoy vs. CNQ's 122.91%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
No Data
No Data available this quarter, please select a different quarter.